VRK1 and lung carcinoma: Consistent with the decrease in phospho-CREB (p-CREB) levels, CCND1 mRNA levels also decreased in response to UA treatment in a concentration-dependent manner in lung cancer cells (Fig. 1f), suggesting that UA blocks the VRK1 downstream signaling pathway, as well as its enzymatic activity.